BRIEF-TaiwanJ Pharmaceuticals starts Phase 2 clinical study on Autoimmune Hepatitis

* Says it began JKB-122 Phase 2 clinical study on Autoimmune

Hepatitis, an orphan disease, in late January and the study is

expected to last for 16 weeks

Read more